Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("COSS, Christopher C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathwaysLI, Chien-Ming; RAMESHNARAYANAN; YANLU et al.International journal of oncology. 2010, Vol 37, Num 4, pp 1023-1030, issn 1019-6439, 8 p.Article

Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifenKIM, Juhyun; COSS, Christopher C; BARRETT, Christina M et al.International journal of cancer (Print). 2013, Vol 132, Num 6, pp 1475-1485, issn 0020-7136, 11 p.Article

Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic BenefitMOHLER, Michael L; BOHL, Casey E; JONES, Amanda et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 12, pp 3597-3617, issn 0022-2623, 21 p.Article

Alanine Aminotransferase Regulation by Androgens in Non-hepatic TissuesCOSS, Christopher C; BAULER, Natt; NARAYANAN, Ramesh et al.Pharmaceutical research. 2012, Vol 29, Num 4, pp 1046-1056, issn 0724-8741, 11 p.Article

Preclinical Characterization of a Novel Diphenyl Benzamide Selective ERα Agonist for Hormone Therapy in Prostate CancerCOSS, Christopher C; JONES, Amanda; DALTON, James T et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1070-1081, issn 0013-7227, 12 p.Article

Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134LIANG, Sheng-Ben; YANG, Xiu-Zhi; GEORGE FANTUS, Ivan et al.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4693-4704, issn 1078-0432, 12 p.Article

Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activitiesATTARDI, Barbara J; PAGE, Stephanie T; HILD, Sheri A et al.Journal of steroid biochemistry and molecular biology. 2010, Vol 118, Num 3, pp 151-161, issn 0960-0760, 11 p.Article

Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized ratsWENQING GAO; REISER, Peter J; COSS, Christopher C et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 11, pp 4887-4897, issn 0013-7227, 11 p.Article

  • Page / 1